4th Quarter - Report

SIGNAL GROUP CONSULTING, LLC for PHRMA (ON BEHALF OF WE WORK FOR HEALTH)

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Issues related to the development of new medical therapies.

LobbyistCovered position, as disclosed
GLYNDA ANN BECKER —
RICK DESIMONE —
JEFF MARKEY —
STEVE MCBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Issues related to intellectual property protections in foreign trade agreements.

LobbyistCovered position, as disclosed
GLYNDA ANN BECKER —
RICK DESIMONE —
JEFF MARKEY —
STEVE MCBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Economics/Economic Development ECN

Issues related to the impact of the bio-pharmaceutical industry on the economy.

LobbyistCovered position, as disclosed
GLYNDA ANN BECKER —
RICK DESIMONE —
JEFF MARKEY —
STEVE MCBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to policy changes to Medicare Part B & D.

LobbyistCovered position, as disclosed
GLYNDA ANN BECKER —
RICK DESIMONE —
JEFF MARKEY —
STEVE MCBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Issues related to access to medicines and other medical therapies, the development of new medical therapies and regulatory matters regarding the bio-pharmaceutical industry.

LobbyistCovered position, as disclosed
GLYNDA ANN BECKER —
RICK DESIMONE —
JEFF MARKEY —
STEVE MCBEE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.